Anthony S. Clark bought $19k of AEF
director at abrdn Emerging Markets ex-China Fund, Inc.. 2,000 shares at an average of $9.73, traded Oct 5, 2026, filed Oct 6, 2026.
Score components
- +15RoleDirector
- 0Trade size$19k at market
- +6Relative to holdingsHoldings up 33%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-113936, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | POpen-market purchase Common Stock | +2,000 | $9.73 | $19k | 8,000 | 7 d ago |
Related signals
Other insiders at abrdn Emerging Markets ex-China Fund, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | AEFbuy abrdn Emerging Markets ex-China Fund, Inc. | Anthony S. Clark director | $43k 4,500 shares | +300% | |
| 23Weak | AEFbuy abrdn Emerging Markets ex-China Fund, Inc. | Anthony S. Clark director | $11k 1,500 shares | - | |
| 25Weak | AEFbuy abrdn Emerging Markets ex-China Fund, Inc. | Nancy Yao director | $5,400 1,000 shares | +100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.